Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

被引：22

作者：

Abeykoon, Jithma P. ^{[1
]}

Murray, David L. ^{[2
]}

Murray, Isaiah ^{[2
]}

Jevremovic, Dragan ^{[2
]}

Otteson, Gregory E. ^{[2
]}

Dispenzieri, Angela ^{[1
]}

Arendt, Bonnie K. ^{[2
]}

Dasari, Surendra ^{[3
]}

Gertz, Morie ^{[1
]}

Gonsalves, Wilson I. ^{[1
]}

Kourelis, Taxiarchis V. ^{[1
]}

Muchtar, Eli ^{[1
]}

Dingli, David ^{[1
]}

Warsame, Rahma ^{[1
]}

Go, Ronald S. ^{[1
]}

Lacy, Martha Q. ^{[1
]}

Leung, Nelson ^{[1
]}

Buadi, Francis ^{[1
]}

Lin, Yi ^{[1
]}

Kyle, Robert A. ^{[1
]}

Rajkumar, Vincent ^{[1
]}

Kumar, Shaji ^{[1
]}

Kapoor, Prashant ^{[1
]}

机构：

[1] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA

[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

[3] Mayo Clin, Dept Hlth Sci & Res, Rochester, MN USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 02期

关键词：

mass spectroscopy; measurable residual disease; prognosis; MINIMAL RESIDUAL DISEASE; FLOW-CYTOMETRY; SPECTROMETRY; SURVIVAL;

D O I：

10.1111/bjh.17195

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Measurable residual disease (MRD) assessment by marrow-based next-generation flow cytometry (NGF) following autologous stem cell transplantation (ASCT) may lead to false-negative results due to patchy marrow involvement and extramedullary disease in patients with multiple myeloma. We assessed the value of simultaneous MRD evaluation with NGF and serum matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MASS-FIX). Of all 61 complete responders who were NGF-negative for MRD, around day-100 post ASCT, 59% were MASS-FIX-positive. At median follow-up of 26 months, 69% of MASS-FIX(+)/NGF(-) patients were alive and progression-free versus 96% of MASS-FIX(-)/NGF(-) patients, P = 0 center dot 02. MASS-FIX, a simple peripheral blood-based assay complements marrow-based NGF to accurately prognosticate patients with myeloma.

引用

页码：380 / 385

页数：6

共 17 条

[1] Is molecular remission the goal of multiple myeloma therapy? [J].

Davies, Faith E. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, :205-211

[2]

DERMAN BA, 2020, J CLIN ONCOL S, V38

[3] Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma [J].

Eveillard, Marion ;

Rustad, Even ;

Roshal, Mikhail ;

Zhang, Yanming ;

Ciardiello, Amanda ;

Korde, Neha ;

Hultcrantz, Malin ;

Lu, Sydney ;

Shah, Urvi ;

Hassoun, Hani ;

Smith, Eric ;

Lesokhin, Alexander ;

Mailankody, Sham ;

Landgren, Ola ;

Thoren, Katie .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) :904-907

[4] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma [J].

Flores-Montero, J. ;

Sanoja-Flores, L. ;

Paiva, B. ;

Puig, N. ;

Garcia-Sanchez, O. ;

Boettcher, S. ;

van der Velden, V. H. J. ;

Perez-Moran, J-J ;

Vidriales, M-B ;

Garcia-Sanz, R. ;

Jimenez, C. ;

Gonzalez, M. ;

Martinez-Lopez, J. ;

Corral-Mateos, A. ;

Grigore, G-E ;

Fluxa, R. ;

Pontes, R. ;

Caetano, J. ;

Sedek, L. ;

del Canizo, M-C ;

Blade, J. ;

Lahuerta, J-J ;

Aguilar, C. ;

Barez, A. ;

Garcia-Mateo, A. ;

Labrador, J. ;

Leoz, P. ;

Aguilera-Sanz, C. ;

San-Miguel, J. ;

Mateos, M-V ;

Durie, B. ;

van Dongen, J. J. M. ;

Orfao, A. .

LEUKEMIA, 2017, 31 (10) :2094-2103

[5] Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement [J].

Gonsalves, Wilson I. ;

Buadi, Francis K. ;

Ailawadhi, Sikander ;

Bergsagel, P. Leif ;

Khan, Asher A. Chanan ;

Dingli, David ;

Dispenzieri, Angela ;

Fonseca, Rafael ;

Hayman, Susan R. ;

Kapoor, Prashant ;

Kourelis, Taxiarchis V. ;

Lacy, Martha Q. ;

Larsen, Jeremy T. ;

Muchtar, Eli ;

Reeder, Craig B. ;

Sher, Taimur ;

Stewart, A. Keith ;

Warsame, Rahma ;

Go, Ronald S. ;

Kyle, Robert A. ;

Leung, Nelson ;

Lin, Yi ;

Lust, John A. ;

Russell, Stephen J. ;

Zeldenrust, Stephen R. ;

Fonder, Amie L. ;

Hwa, Yi L. ;

Hobbs, Miriam A. ;

Mayo, Angela A. ;

Hogan, William J. ;

Rajkumar, S. Vincent ;

Kumar, Shaji K. ;

Gertz, Morie A. ;

Roy, Vivek .

BONE MARROW TRANSPLANTATION, 2019, 54 (03) :353-367

[6] Value of serum free light chain testing for the diagnosis and monitoring of monoclonal gammopathies in hematology [J].

Jagannath, Sundar .

CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (08) :518-523

[7] Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma [J].

Kendrick, Felicity ;

Evans, Neil D. ;

Arnulf, Bertrand ;

Avet-Loiseau, Herve ;

Decaux, Olivier ;

Dejoie, Thomas ;

Fouquet, Guillemette ;

Guidez, Stephanie ;

Harel, Stephanie ;

Hebraud, Benjamin ;

Javaugue, Vincent ;

Richez, Valentine ;

Schraen, Susanna ;

Touzeau, Cyrille ;

Moreau, Philippe ;

Leleu, Xavier ;

Harding, Stephen ;

Chappell, Michael J. .

FRONTIERS IN PHYSIOLOGY, 2017, 8

[8] Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients [J].

Krejci, M ;

Buchler, T ;

Hajek, R ;

Svobodnik, A ;

Krivanova, A ;

Pour, L ;

Adam, Z ;

Mayer, J ;

Vorlicek, J .

BONE MARROW TRANSPLANTATION, 2005, 35 (02) :159-164

[9] International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma [J].

Kumar, Shaji ;

Paiva, Bruno ;

Anderson, Kenneth C. ;

Durie, Brian ;

Landgren, Ola ;

Moreau, Philippe ;

Munshi, Nikhil ;

Lonial, Sagar ;

Blade, Joan ;

Mateos, Maria-Victoria ;

Dimopoulos, Meletios ;

Kastritis, Efstathios ;

Boccadoro, Mario ;

Orlowski, Robert ;

Goldschmidt, Hartmut ;

Spencer, Andrew ;

Hou, Jian ;

Chng, Wee Joo ;

Usmani, Saad Z. ;

Zamagni, Elena ;

Shimizu, Kazuyuki ;

Jagannath, Sundar ;

Johnsen, Hans E. ;

Terpos, Evangelos ;

Reiman, Anthony ;

Kyle, Robert A. ;

Sonneveld, Pieter ;

Richardson, Paul G. ;

McCarthy, Philip ;

Ludwig, Heinz ;

Chen, Wenming ;

Cavo, Michele ;

Harousseau, Jean-Luc ;

Lentzsch, Suzanne ;

Hillengass, Jens ;

Palumbo, Antonio ;

Orfao, Alberto ;

Rajkumar, S. Vincent ;

Miguel, Jesus San ;

Avet-Loiseau, Herve .

LANCET ONCOLOGY, 2016, 17 (08) :E328-E346

[10] The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic [J].

Milani, Paolo ;

Murray, David L. ;

Barnidge, David R. ;

Kohlhagen, Mindy C. ;

Mills, John R. ;

Merlini, Giampaolo ;

Dasari, Surendra ;

Dispenzieri, Angela .

AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) :772-779

← 1 2 →